At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
Dario Blood Glucose Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dario Blood Glucose Monitoring System - Android Devices User Performance
In Brief
A clinical study evaluating Dario Blood Glucose Monitoring System for Diabetes Mellitus. Completed, enrolled 102 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the accuracy of the Dario Blood Glucose Monitoring System as compared to a reference method (Yellow Springs Instrument 2300 STAT Plus) and to evaluate the usability of the device when used by laypersons.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
Primary CompletionJul 2016
Study CompletionAug 2016
First PostedSep 2016
TodayJul 2026
First PostedSep 22, 2016
Enrollment StartJul 1, 2016
Primary CompletionJul 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 9.8 years ago
Interventions
Dario Blood Glucose Monitoring Systemdevice
Accuracy with usability assessment